DAIC

JANUARY 23, 2024

3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardial infarction (MI), stroke, and cardiovascular (CV) death.4 milligrams per liter (mg/L) are linked to increased risk of heart attacks or risk of a repeat heart attack.23 4 In the U.S.

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

CardiacWire

APRIL 24, 2024

The authors believe that the current MI diagnosis criteria (symptoms of coronary ischemia + abnormal troponin levels) isn’t sufficient, and the liberal use of troponin testing (particularly in the US) has compounded this problem. myocarditis) for one-fifth of the participants. So what’s causing this trend towards MI overdiagnosis?

Myocardial Infarction 59

Myocardial Infarction Chest Pain Biomarkers Ischemia 59

Dr. Anish Koka

MAY 16, 2023

There may be no better study to symbolize the dysfunction that has invaded cardiology than the VIRGO trial, a study examining the outcomes of young patients (18-55) presenting to the hospital with a heart attack. More cardiac injury means more dead heart muscle, and a larger scar. This happens. But its rare! for MINOCA patients.

Chest Pain 52

Chest Pain Coronary Artery Disease Cancer Heart Attack 52

Dr. Smith's ECG Blog

AUGUST 9, 2024

He reported a history of “Wolf-Parkinson-White” and “heart attack” but said neither had been treated. Frick -- one wonders about the diagnosis of unstable angina in a patient with significantly elevated biomarkers which would certainly have been rising on repeat measurement.) And is there new left bundle branch block (LBBB)?

Chest Pain 88

Chest Pain Arrhythmia Myocardial Infarction STEMI 88